Grail

Company GRAL

Last mentioned: 3d ago

Timeline

  1. Candel Public Offering

    Candel Therapeutics prices $100M public offering at $5.45 per share.

  2. Trial Data Release

    Grail shares slide as NHS-Galleri trial misses primary endpoint for late-stage cancer reduction.

  3. GDP Release

    U.S. government scheduled to release Q4 GDP growth figures at 8:30 AM ET.

  4. Grail Earnings

    Grail reports Q4 and Full Year 2025 financial results, beating revenue and EPS estimates.

Stories mentioning Grail 1

Markets Bullish

US Futures Rebound as Markets Await Pivotal Q4 GDP Growth Data

US equity futures signaled a positive open on Friday as investors shifted focus toward the release of fourth-quarter GDP figures. Following a lackluster Thursday session, the market is looking for confirmation of economic resilience while monitoring individual movers like Grail and Candel Therapeutics.

2 sources